Report
Jonathan Moreland
EUR 9.40 For Business Accounts Only

InsiderInsights Weekly Tables: June 13, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
ACCELERATE DIAGNOSTICS INC.

Accelerate Diagnostics is an in vitro diagnostics company. The company's Accelerate Pheno? system utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial and fungal cells are resistant or susceptible to a particular antimicrobial. The Accelerate PhenoTest? BC Kit, which is the test kit for the system, provides ID and AST results for patients suspected of bacteremia or fungemia, both conditions with morbidity and mortality risk. The Accelerate Pheno? system comprises of a robotic pipettor for fluidic manipulation, an optical system, and an imaging system.

Affiliated Managers Group Inc.

Affiliated Managers Group is a global asset management company with equity investments in boutique investment management firms (Affiliates). The company provides centralized capabilities to its Affiliates, including strategy, marketing and distribution, and product development. Through its Affiliates, the company provides strategies designed to assist institutional, retail and clients worldwide in achieving their investment objectives. The company provides boutique investment management services to retail investors through advisory and sub-advisory services to return-oriented mutual funds, Undertakings for the Collective Investment of Transferable Securities, collective investment trusts and other retail products.

Aileron Therapeutics

Aileron Therapeutics is a biopharmaceutical company that develops and commercializes stabilized cell-permeating alpha-helical peptides to address intracellular targets in oncology and other therapeutic areas. The company's product candidate, ALRN-6924, is a cell-permeating peptide that mimics the p53 tumor suppressor protein to disrupt p53's interactions with its endogenous inhibitors, MDMX and MDM2. ALRN-6924 is designed to activate the mechanisms used by p53 in cells with non-mutant, or wild-type, p53 to regulate cell division and progression through the cell replication cycle, programmed death of cancerous cells, or apoptosis, and induction of the immune system to respond against cancer cells.

Alliance Data Systems Corporation

Alliance Data Systems is a provider of data-driven marketing and loyalty solutions. The company operates in two segments: LoyaltyOne? and Card Services. LoyaltyOne provides coalition and short-term loyalty programs through the Canadian AIR MILES? Reward Program and BrandLoyalty Group B.V. Card Services encompasses credit card processing, billing and payment processing, customer care and collections services for private label retailers as well as private label and co-brand retail credit card and loan receivables financing, including securitization and other funding of certain credit card and loan receivables that it underwrites from its private label and co-brand retail credit card programs.

American Woodmark Corporation

American Woodmark manufactures and distributes kitchen, bath and home organization products for the remodeling and new home construction markets. The company provides a variety of products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization and hardware. The company's cabinetry products are available in a variety of designs, finishes and finish colors and door styles. The company provides products in the following categories: made-to-order, which are special ordered and shipped directly to the home from the factory; and stock, which represents cash and carry products sold through home centers. The company's home organization products are stock products.

Amyris

Amyris is an industrial biotechnology company that applies its technology platform to engineer, manufacture and sell products into the Health and Wellness, Clean Beauty, and Flavor and Fragrance markets. The company's technology platform enables it to engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into ingredients. The company is focused on the production of Biofene?, its brand of renewable farnesene, a long-chain, branched hydrocarbon molecule that it manufactures through fermentation using engineered microbes. The company's farnesene derivatives are sold in various products as nutrition, health, skincare, fragrances, solvents, and fragrance ingredients.

Applied DNA Sciences Inc.

Applied DNA Sciences manufactures linear deoxyribonucleic acid (DNA) for use in its proprietary products as well as for sale to third parties. The company manufactures non-biological DNA-based molecular taggants for use in its proprietary supply chain security, anticounterfeiting, brand protection and law enforcement products. Through its subsidiary, LineaRx, Inc., the company supplies polymerase chain reaction produced linear DNA for use in preclinical biotherapeutic applications including CAR T/TCR, RNA manufacture, DNA-based vaccines and gene therapies, as well as in vitro diagnostics.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary oral drug candidate, MDX, to treat ADHD and other cognitive dysfunctions including Fragile X Syndrome. The most common available treatments for ADHD are stimulants that increase the brain chemicals dopamine and norepinephrine. Stimulants have significant side effects, and are classified as controlled substances which have significant potential for misuse, abuse and addiction. MDX is not a stimulant, and works with a different mechanism of action. MDX is a proprietary, combined rapid onset release formulation of the chemical Pyridoxine Pyroglutamate.

Arcus Biosciences

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer immunotherapies. The company has four clinical-stage product candidates: AB928, which is an orally bioavailable, reversible antagonist of the adenosine 2a and adenosine 2b receptors; AB680, which is a reversible and selective inhibitor of the CD73 enzyme; AB122, which is a human antibody with similar binding affinity and other characteristics to the marketed anti-PD-1 antibodies pembrolizumab and nivolumab; and AB154, which is a humanized antibody that inhibits an immune checkpoint target involved in a pathway that plays both inhibitory and stimulatory roles in the immune system.

Associated Banc-Corp

Associated Banc is a bank holding company. Through its subsidiaries, the company provides banking and nonbanking products and services. The company has three segments: Corporate and Commercial Specialty, which includes lending solutions, deposit and cash management solutions, and financial services; Community, Consumer, and Business, which includes lending solutions, deposit and transactional solutions, investable funds solutions, trust and investment management accounts, insurance and benefits-related products and services, and fiduciary services; and Risk Management and Shared Services, which includes corporate risk management, credit administration, finance, treasury, and operations and technology.

Athene Holding Ltd. Class A

Atmos Energy Corporation

Atmos Energy is engaged in the regulated natural gas distribution and pipeline and storage businesses. The company delivers natural gas through regulated sales and transportation arrangements to residential, commercial, public-authority and industrial customers. The company's segments are: Distribution, which is comprised of its regulated natural gas distribution and related sales operations; and Pipeline and Storage, which consists of the pipeline and storage operations of its Atmos Pipeline-Texas Division (APT) and its natural gas transmission operations in Louisiana. APT has intrastate pipeline operations in Texas with a focus on the natural gas-producing areas of central, northern and eastern Texas.

Avid Technology Inc.

Avid Technology develops, markets, sells, and supports software and solutions for video and audio content creation, management and distribution. The company's solutions are used in production and post-production facilities; film studios; network, affiliate, independent and cable television stations; recording studios; live-sound performance venues; advertising agencies; government and educational institutions; corporate communications departments; and by independent video and audio creative professionals. Projects produced using the company's tools include feature films, television programming, live events, news broadcasts, sports productions, commercials, music, video and other digital media content.

B Riley Securities Inc

B. Riley Financial and its subsidiaries provide investment banking and financial services to corporate, institutional and high net worth clients, and asset disposition, valuation and appraisal and capital advisory services to a range of retail, wholesale and industrial clients, as well as lenders, capital providers, private equity investors and professional services firms throughout the U.S., Australia, Canada, and Europe. The company also provides consumer Internet access and related subscription services. The company's operating segments are: Capital Markets, Auction and Liquidation, Valuation and Appraisal, and Principal Investments - United Online and magicJack.

Babcock & Wilcox Enterprises

Babcock & Wilcox Enterprises is a technology-based provider of steam production from fossil and renewable sources. The company's segments are: Babcock & Wilcox, which focuses on the supply of, and aftermarket services for, steam-generating, environmental, and auxiliary equipment for power generation and other industrial applications; Volund & Other Renewable, which provides steam-generating systems, environmental and auxiliary equipment for the waste-to-energy and biomass power generation industries, and plant operations and maintenance services for its systems and equipment; and SPIG S.p.A. (SPIG), which provides custom-engineered cooling systems, services and aftermarket products.

Bain Capital Specialty Finance

Bausch Health Companies Inc.

Blue Apron Holdings

Blue Apron provides recipes, ingredients, and cooking techniques. The company's products include: meals, which consist of a Two-Serving Plan that serves two people, and a Family Plan that serves four people; wine, through Blue Apron Wine delivery service to deliver wines, including red and white wines (and roses, depending on the season), tasting notes, pairing tips, and the story behind each wine; market, which features a selection of cooking tools, utensils, and pantry items through its e-commerce marketplace, Blue Apron Market; and digital experience, which provides how-to cooking videos, stories about its suppliers, and its collection of various recipes that customers can access on their own.

Camping World Holdings Inc. Class A

Camping World Holdings is a holding company. Through its subsidiaries, the company is a retailer of recreational vehicles (RVs) and RV-related products and services, and a retailer of outdoor lifestyle and active sports-related products and services. The company's segments include: consumer services and plans, which provides extended vehicle service contracts, emergency roadside assistance, property and casualty insurance programs, membership clubs, vehicle financing and refinancing, travel protection, and co-branded credit cards; dealership, which provides new vehicles and used vehicles; and retail, which includes: RV supply and maintenance products, and outdoor equipment and recreational products.

Celldex Therapeutics Inc.

Celldex Therapeutics is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company has four drug candidates in clinical development, including CDX-1140, an agonist human monoclonal antibody targeted to CD40, a key activator of immune response; CDX-3379, a human monoclonal antibody designed to block the activity of ErbB3; varlilumab, an immune modulating antibody targeting CD27 designed to improve a patient's immune response; and CDX-301, a dendritic cell growth factor.

Cellectar Biosciences

Centennial Resource Development Inc. Class A

Centennial Resource Development is an independent oil and natural gas company focused on the development of unconventional oil and associated natural gas reserves in the Permian Basin.

Century Bancorp Inc. Cl A

Century Bancorp is a bank holding company. Through its subsidiary, Century Bank and Trust Company, the company provides services to commercial enterprises, state and local governments and agencies, non-profit organizations and individuals. The company also provides securities brokerage services through a program called Investment Services at Century Bank, which is supported by LPL Financial, a third party securities brokerage business. The company grants single-family and multi-family residential loans, commercial and commercial real estate loans, municipal loans, and a variety of consumer loans. In addition, the company provides savings accounts, NOW accounts, demand deposits, time deposits and money market accounts.

CERECOR INC

Cerecor is a biopharmaceutical company. The company is building a pipeline of therapies in neurology, pediatric healthcare, and orphan rare diseases. The company's neurology pipeline is led by CERC-301, which is in a Phase I safety study for Neurogenic Orthostatic Hypotension. The company is also developing two other neurological clinical and preclinical stage compounds. The company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. All three of these compounds are preclinical therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation by means of substrate replacement therapy.

Change Healthcare Inc.

CNA Financial Corporation

CNA Financial is an insurance holding company. The company's property and casualty and remaining life and group insurance operations are primarily conducted by its subsidiaries. The company's insurance products primarily include commercial property and casualty coverages, including surety. The company's services include warranty, risk management information services and claims administration. The company's commercial property and casualty underwriting operations in the United States consists of field underwriting locations and centralized processing operations which handle policy processing, billing and collection activities and also act as call centers to support service.

Counterpath

Eaton Vance Senior Income Trust

Entasis Therapeutics Holdings

Entasis Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. The company's lead product candidate, ETX2514, as well as one of its other product candidates, ETX0282, inhibit one of the most prevalent forms of bacterial resistance, ?-lactamase enzymes, so named because of their ability to inactivate ?-lactam antibiotics. The company's other product candidate, zoliflodacin, targets the validated mechanism of action of the fluoroquinolone class of antibiotics, but does so in a manner to avoid existing fluoroquinolone resistance.

Extreme Networks Inc.

Extreme Networks, together with its subsidiaries, is a provider of software-driven networking solutions for enterprise, data center, and service provider customers. Providing a combined end-to-end solution from the enterprise edge to the cloud, the company designs, develops, and manufactures wired and wireless network infrastructure equipment and develops the software for network management, policy, analytics, security, and access controls. The company's product categories include: Smart OmniEdge wireless and edge switching, Automated Campus, data center, unified applications, and cloud-based network management.

FibroGen Inc.

FibroGen is a biopharmaceutical company engaged in discovering, developing and commercializing a pipeline of therapeutics. The company applies its capability in hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. Roxadustat, the company's primary product, is an inhibitor of HIF prolyl hydroxylase that acts by stimulating the body's natural pathway of erythropoiesis, or red blood cell production. Pamrevlumab is the company's human monoclonal antibody that inhibits the activity of CTGF, a central mediator and key common element in the progression of fibrotic and fibro-proliferative diseases.

Flexsteel Industries Inc.

Flexsteel Industries is a manufacturer, importer and marketer of residential and contract upholstered and wooden furniture products. With offerings for use in home, healthcare, and recreational seating, the company distributes its furniture throughout the United States and Canada through the company's sales force and various independent representatives. The company operates in one reportable segment, furniture products. The company's furniture products business involves the distribution of manufactured and imported products consisting of a line of upholstered and wooden furniture for residential and contract markets.

Fossil Group Inc.

Fossil Group is a design, marketing and distribution company that focuses on consumer fashion accessories. The company's principal offerings include a line of men's and women's fashion watches and jewelry, handbags, small leather goods, belts and sunglasses. The company's products are distributed through various distribution channels, including wholesale in countries where the company has a physical presence, direct to the consumer through the company's retail stores and commercial websites and through third-party distributors in countries where the company does not maintain a physical presence. The company's reportable operating segments are comprised of Americas, Europe, and Asia.

Kala Pharmaceuticals Inc.

Kala Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics using its AMPPLIFY? Mucus Penetrating Particles drug delivery technology, with a focus on the treatment of eye diseases. The company's approved ocular corticosteroid product, INVELTYS? (loteprednol etabonate ophthalmic suspension) is used for the treatment of post-operative inflammation and pain. The company is developing KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease. The company is evaluating compounds in its receptor Tyrosine Kinase Inhibitor program that inhibit the vascular endothelial growth factor pathway for the treatment of a number of retinal diseases.

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health. The company offers treatment for hyperammonemia, a metabolic condition generally characterized by elevated levels of ammonia in the blood; infections caused by multi-drug resistant bacteria; chronic kidney disease; atherosclerotic cardiovascular disease; and drug or disease induced diarrhea. The company's product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Kezar Life Sciences

Kezar Life Sciences is a clinical-stage biotechnology company, discovering and developing small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The company's product candidate, KZR-616, an immunoproteasome inhibitor, is enrolling a clinical trial across different separate autoimmune indications: lupus nephritis; autoimmune hemolytic anemia, and immune thrombocytopenia; and dermatomyositis, and polymyositis. The company is also utilizing its protein secretion pathway research platform to discover and develop small molecule therapies targeting oncology indications.

Liberty Media Corp. Series A Liberty SiriusXM

Liberty Media Corp. Series C Liberty SiriusXM

Liberty Media - SiriusXM Group transmits music, sports, entertainment, comedy, talk, news, traffic and weather channels, as well as infotainment services, in the United States on a subscription fee basis through its two satellite radio systems. Subscribers can also receive music and other channels, plus features such as SiriusXM On Demand and MySXM, over its Internet radio service, including through applications for mobile devices, home devices and other consumer electronic equipment. As of Dec 31 2016, SIRIUS XM had approximately 31.3 million subscribers.

Liquidity Services

Liquidity Services is engaged in operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an automated environment. The company's reportable segments are: Retail Supply Chain Group, which consists of marketplaces that enable corporations to sell surplus and salvage consumer goods and retail capital assets; Capital Assets Group, which provides solutions to sellers and it consists of marketplaces that enable commercial businesses to sell surplus, salvage, and scrap assets; GovDeals, which provides self-directed service solutions; and Machinio, which operates an online platform for listing used equipment for sale in the construction, machine tool, among others.

Menlo Therapeutics Inc

Menlo Therapeutics is a late-stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company is concurrently evaluating the use of serlopitant for the treatment of refractory chronic cough, a cough that persists for at least eight weeks despite treatment of any identified underlying cause. The company's product candidate, serlopitant, is a highly selective once-daily, oral small molecule inhibitor of the neurokinin 1 receptor, or NK1-R, that has the potential to alleviate itch and cough symptoms.

MERUS B V

Mountain Crest Acquisition Corp.

Northern Oil & Gas Inc.

Northern Oil and Gas is an independent energy company engaged in the acquisition, exploration, development and production of oil and natural gas properties, primarily in the Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana. The company's primary focus is oil exploration and production through non-operated working interests in wells drilled and completed in spacing units that include its acreage. As a non-operator, the company is able to diversify its investment exposure by participating in a number of gross wells, as well as entering into project areas by partnering with operating partners.

Old Republic International Corporation

Old Republic International is a holding company engaged in the business of insurance underwriting and related services. Through its regulated insurance company subsidiaries, the company conducts its operations in three main segments: General Insurance Group, which is a commercial lines insurance business focused on liability insurance coverages; Title Insurance Group, which consists mainly of the issuance of policies to real estate purchasers and investors based upon searches of the public records, which contain information concerning interests in real property; and the Republic Financial Indemnity Group Run-off Business, which consists of mortgage guaranty and consumer credit indemnity operations.

Pinnacle Financial Partners Inc.

Pinnacle Financial Partners is a bank holding company. Through its subsidiary, Pinnacle Bank, the company provides banking services, including investment, mortgage, and insurance services, and wealth management services. The company provides a range of lending products, including commercial, real estate and consumer loans to individuals and small-to medium-sized businesses and other entities. Pinnacle Bank's deposit services include savings, checking, noninterest-bearing checking, interest-bearing checking, money market and certificate of deposit accounts. Pinnacle Bank contracts with Raymond James Financial Services, Inc. to provide and sell various securities and other financial products to the public.

Pioneer Floating Rate

Resideo Technologies, Inc.

S&W Seed Co

S&W Seed is an agricultural company engaged in breeding, growing, processing and selling agricultural seeds, primarily alfalfa seed. The company also has a commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers worldwide. The company's portfolio of alfalfa seed products includes varieties that, depending upon the particular variety, exhibit traits that forage hay farmers required, such as high yield, root rot resistance, lodging resistance, salt tolerance, drought tolerance, leafhopper resistance and stem nematode resistance.

Select Interior Concepts

Select Interior Concepts is an installer and nationwide distributor of interior building products with market positions in residential interior design services. The company's two reportable segments are: Residential Design Services, which is a service business that provides design center operation, interior design, product sourcing, and installation services to homebuilders, homeowners, general contractors and property managers; and Architectural Surfaces Group, which distributes granite, marble, and quartz slabs for countertop and other uses, and ceramic and porcelain tile for flooring and backsplash and wall tile applications.

Sonim Technologies

Sonim Technologies is a provider of ultra-rugged mobile phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company offers ruggedized mobile phones, such as Sonim XP8, Sonim XP5s, and Sonim XP3 based on the Android platform that are capable of attaching to public and private wireless networks; industrial-grade accessories, including remote speaker microphones, multi-bay charging accessories, and in-vehicle hands-free voice communications solutions; and cloud-based software and application services. The company sells its mobile phones and accessories primarily to wireless carriers in the United States and Canada.

TherapeuticsMD Inc.

TherapeuticsMD is a women's healthcare company focused on creating and commercializing products to support women's healthcare issues for pregnancy prevention, pregnancy, childbirth, nursing, pre-menopause, and menopause. The company's solutions range from hormone therapy pharmaceutical products to patient-controlled, long-acting contraceptive. The company also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaMedMD? and BocaGreenMD? brands. The company's hormone therapy drugs include: IMVEXXY? for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity); and ANNOVERA?, a one-year ring-shaped contraceptive vaginal system.

Watford Holdings

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch